Academic literature on the topic 'Pro-liposome'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pro-liposome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pro-liposome"

1

Yadav, Chandan, Md Asif, Juber Akhtar, et al. "An outline on curcumin: Its pro-liposome and liposome formulations." RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY 13, no. 12 (2020): 6276–83. http://dx.doi.org/10.5958/0974-360x.2020.01092.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hirose, Masanori, Shigenori Sugisaki, Keishi Suga, and Hiroshi Umakoshi. "Detection of L-Proline-Catalyzed Michael Addition Reaction in Model Biomembrane." Journal of Chemistry 2019 (February 26, 2019): 1–8. http://dx.doi.org/10.1155/2019/4926435.

Full text
Abstract:
A method to detect the L-proline- (L-Pro-) catalyzed Michael addition reaction in model biomembranes has been established, using N-[p(2-benzimidazolyl)phenyl]maleimide and acetone as reactants. The effect of liposome membranes on this reaction was kinetically analyzed using fluorescence spectroscopy. The kinetics of the reaction were different from those of the constituent lipids of the liposomes. Zwitterionic 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposome, which is in the solid-ordered phase, had a better value of reaction rate, suggesting that the reaction rate constants of this reacti
APA, Harvard, Vancouver, ISO, and other styles
3

Prajakta, Kangutkar* Samruddhi More Shital Kambale Dr. D. R. Jadage. "A Review: Proliposomes As Effective and Stable Drug Delivery System." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 1021–30. https://doi.org/10.5281/zenodo.15352388.

Full text
Abstract:
A new medication delivery method called proliposomes uses dry, granular materials that, when hydrated, produce liposomal solutions. Enhanced stability, prolonged drug release, and better bioavailability are all provided by them. Size, in vitro drug release, and trapping effectiveness are characteristics of proliposomes, which can be made in a variety of ways. They may find use in pulmonary, topical, and oral administration, especially for medications that are poorly soluble. By offering targeted distribution, proliposomes can increase treatment efficacy and lessen adverse effects. They are a d
APA, Harvard, Vancouver, ISO, and other styles
4

Sanchez-Aranguren, Lissette, Milda Grubliauskiene, Hala Shokr, et al. "Sodium Thiosulphate-Loaded Liposomes Control Hydrogen Sulphide Release and Retain Its Biological Properties in Hypoxia-like Environment." Antioxidants 11, no. 11 (2022): 2092. http://dx.doi.org/10.3390/antiox11112092.

Full text
Abstract:
Hypoxia, or insufficient oxygen availability is a common feature in the development of a myriad of cardiovascular-related conditions including ischemic disease. Hydrogen sulphide (H2S) donors, such as sodium thiosulphate (STS), are known for their cardioprotective properties. However, H2S due to its gaseous nature, is released and cleared rapidly, limiting its potential translation to clinical settings. For the first time, we developed and characterised liposome formulations encapsulating STS and explored their potential for modulating STS uptake, H2S release and the ability to retain pro-angi
APA, Harvard, Vancouver, ISO, and other styles
5

Zhang, Ying, Haijing Qu, and Xiangdong Xue. "Blood–brain barrier penetrating liposomes with synergistic chemotherapy for glioblastoma treatment." Biomaterials Science 10, no. 2 (2022): 423–34. http://dx.doi.org/10.1039/d1bm01506k.

Full text
Abstract:
A temozolomide and pro-apoptotic peptide co-loading liposome with blood–brain barrier penetrating capability exhibits highly synergistic and effective anti-tumor effect on both subcutaneous and intracranial glioblastoma mouse models.
APA, Harvard, Vancouver, ISO, and other styles
6

Lu, Yuan, Dankui Liao, Xuezhen Feng, et al. "Development and Adsorption Characterization of Metal Affinity-Immobilized Magnetic Liposome." Journal of Nanomaterials 2020 (February 11, 2020): 1–8. http://dx.doi.org/10.1155/2020/8731360.

Full text
Abstract:
A metal affinity-immobilized magnetic liposome (MA-IML) was prepared in this research, which was with lipid and Ni2+ content of 143.25 μg/mg and 32 μmol/mg, respectively. The antihypertensive peptides Ile-Pro-Pro (IPP) and Val-Pro-Pro (VPP) could be adsorbed onto MA-IML under specific conditions, and the adsorption kinetics was explored. The pseudo-second-order kinetics (R2 value>0.98) was more suitable to describe the adsorption process of IPP and VPP than the intraparticle diffusion model and pseudo-first-order kinetic model. The results indicated that MA-IML could be used as an adsorbent
APA, Harvard, Vancouver, ISO, and other styles
7

An, Duopeng, Xiaochen Yu, Lijing Jiang, et al. "Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment." Molecules 26, no. 5 (2021): 1280. http://dx.doi.org/10.3390/molecules26051280.

Full text
Abstract:
Multidrug resistance (MDR) remains a major problem in cancer therapy and is characterized by the overexpression of p-glycoprotein (P-gp) efflux pump, upregulation of anti-apoptotic proteins or downregulation of pro-apoptotic proteins. In this study, an Apolipoprotein A1 (ApoA1)-modified cationic liposome containing a synthetic cationic lipid and cholesterol was developed for the delivery of a small-molecule chemotherapeutic drug, doxorubicin (Dox) to treat MDR tumor. The liposome-modified by ApoA1 was found to promote drug uptake and elicit better therapeutic effects than free Dox and liposome
APA, Harvard, Vancouver, ISO, and other styles
8

Kundawala, Aliasgar J., Khushbu S. Chauhan, Harsha V. Patel, and Swati K. Kurtkoti. "Inhalable Spray Dried Pro-Liposome Powder Containing Budesonide for Pulmonary Delivery." International Journal of Pharmaceutical Sciences and Nanotechnology 14, no. 4 (2021): 5538–48. http://dx.doi.org/10.37285/ijpsn.2021.14.4.3.

Full text
Abstract:
Budesonide is an anti-asthmatic agent which is used to control the symptoms of asthma like bronchospasm, oedema. Drug delivered to lung through inhalation will provide systemic and local drug delivery at lower dose in chronic and acute diseases. Dry powder inhalers are the best choice for targeting the anti-asthmatic drugs through pulmonary route. The objective of the present study is to prepare inhalable lipid coated budesonide microparticles by spray drying method so effective delivery of budesonide to the lungs can be achieved. The microparticles in the form of dry powder were obtained by e
APA, Harvard, Vancouver, ISO, and other styles
9

Gaspar, Maria Manuela, Oliviero Gobbo, and Carsten Ehrhardt. "Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers." Journal of Liposome Research 20, no. 1 (2010): 55–61. http://dx.doi.org/10.3109/08982100903085150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gaspar, Maria Manuela, Oliviero Gobbo, and Carsten Ehrhardt. "Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers." Journal of Liposome Research 00, no. 00 (2009): 090706063146008–7. http://dx.doi.org/10.1080/08982100903085150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pro-liposome"

1

Tshanga, Siphokazi Sisanda. "Antibacterial activity of liposome encapsulated cyclo(TYR-PRO)." Thesis, Nelson Mandela Metropolitan University, 2011. http://hdl.handle.net/10948/1450.

Full text
Abstract:
Cyclic dipeptides (CDPs) are amino acid-based compounds, some of which possess antibacterial activity. The encapsulation of certain drugs into liposomes has been found to improve their activity in terms of bioavailability and duration of action. Liposomes are small vesicles that are under investigation as drug carriers for the delivery of therapeutic agents. A number of liposome formulations are currently under clinical trial review, whilst some have already been approved for clinical use. The aim of this study was to optimize a liposomal cyclo(Tyr-Pro) formulation and to assess its antibacter
APA, Harvard, Vancouver, ISO, and other styles
2

Moon, Taylor J. "Development of a Dual-Agonist Immunostimulatory Nanoparticle to Trigger Interferon β-Driven Anti-Tumor Immunity". Case Western Reserve University School of Graduate Studies / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=case1607349015331713.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pro-liposome"

1

Takahashi, Atsushi, Kousuke Hiromori, Naomi Shibasaki-Kitakawa, and Ryota Takahashi. "Quantitative Evaluation of Oxidative Stability of Biomembrane Lipids in the Presence of Vitamin E." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/zlem3137.

Full text
Abstract:
In this report, the oxidation of biomembranelipids, phospholipid (LH) and cholesterol (ChH), was examined experimentally in the presence of vitamin E (VEH) by using a liposome system, which is widely used as a biomembrane model. A kinetic model was constructed by taking into account mechanisms of antioxidation and pro-oxidation by VEH and the co-oxidation mechanisms of biomembrane lipids reported previously (Takahashi et al., 2016). The model constants for VEH-related reactions were estimated based on the experimental results. The model quantitatively described the concentration profiles of LH
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!